Nanoparticulate Drug Delivery to the Retina
The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Abstract
Retinal diseases, such as age-related macular degeneration and diabetic retinopathy, are the leading causes of blindness worldwide. The mainstay of treatment for these blinding diseases remains to be surgery, and the available pharmaceutical therapies on the market are limited, partially owing to various biological barriers in hindering the delivery of therapeutics to the retina. The nanoparticulate drug delivery system confers the capability for delivering therapeutics to the specific ocular targets and, hence, potentially revolutionizes the current treatment landscape of retinal diseases. While the research to date indicates the enormous therapeutics potentials of the nanoparticulate delivery systems, the successful translation of these systems from the bench to bedside is challenging and requires a combined understanding of retinal pathology, physiology of the eye, and particle and formulation designs of nanoparticles. To this end, the review begins with an overview of the most prevalent retinal diseases and related pharmacotherapy. Highlights of the current challenges encountered in ocular drug delivery for each administration route are provided, followed by critical appraisal of various nanoparticulate drug delivery systems for the retinal diseases, including their formulation designs, therapeutic merits, limitations, and future direction. It is believed that a greater understanding of the nano-biointeraction in eyes will lead to the development of more sophisticated dru…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Polymer nanoparticles: Preparation techniques and size-control parameters
Rao, J. P., & Geckeler, K. E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.01.001 · Cited by 1,725
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Amphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078
International Journal of Ophthalmology
(2020) · International Journal of Ophthalmology · doi:10.18240/ijo · Cited by 597
Diabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 424
Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences
Pastor, J. C., Rojas, J., Pastor-Idoate, S., Di Lauro, S., Gonzalez-Buendia, L., & Delgado-Tirado, S. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.07.005 · Cited by 344
Drug delivery to the posterior segment of the eye
Thrimawithana, T. R., Young, S., Bunt, C. R., Green, C., & Alany, R. G. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.12.004 · Cited by 335
Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo
Xu, Q., Boylan, N. J., Suk, J. S., Wang, Y.-Y., Nance, E. A., Yang, J.-C., McDonnell, P. J., Cone, R. A., Duh, E. J., & Hanes, J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.018 · Cited by 326
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
Kompella, U. B., Amrite, A. C., Pacha Ravi, R., & Durazo, S. A. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.04.001 · Cited by 258
Almeida, H., Amaral, M. H., Lobão, P., & Lobo, J. M. S. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.001 · Cited by 257
Periocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.99 · Cited by 257
Ghazi, N. G., Abboud, E. B., Nowilaty, S. R., Alkuraya, H., Alhommadi, A., Cai, H., Hou, R., Deng, W.-T., Boye, S. L., Almaghamsi, A., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1637-y · Cited by 243
Liposomes for intravitreal drug delivery: A state of the art
Bochot, A., & Fattal, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.019 · Cited by 227
Kim, J. H., Kim, J. H., Kim, K.-W., Kim, M. H., & Yu, Y. S. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/50/505101 · Cited by 226
Omri, S., Behar-Cohen, F., de Kozak, Y., Sennlaub, F., Mafra Verissimo, L., Jonet, L., Savoldelli, M., Omri, B., & Crisanti, P. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.018 · Cited by 213
Singh, S. R., Grossniklaus, H. E., Kang, S. J., Edelhauser, H. F., Ambati, B. K., & Kompella, U. B. (2009) · Gene Therapy · doi:10.1038/gt.2008.185 · Cited by 204
Recent Advances in Ocular Drug Delivery Systems
Kuno, N., & Fujii, S. (2011) · Polymers · doi:10.3390/polym3010193 · Cited by 202
Hosoya, K.-I., Lee, V. H. L., & Kim, K.-J. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.12.007 · Cited by 194
Iezzi, R., Guru, B. R., Glybina, I. V., Mishra, M. K., Kennedy, A., & Kannan, R. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.010 · Cited by 192
ABRISHAMI, M., GANAVATI, S. Z., SOROUSH, D., ROUHBAKHSH, M., JAAFARI, M. R., & MALAEKEH-NIKOUEI, B. (2009) · Retina · doi:10.1097/iae.0b013e3181a2f42a · Cited by 184
Quiram, P. A., Gonzales, C. R., Hu, W., Gupta, A., Yoshizumi, M. O., Kreiger, A. E., & Schwartz, S. D. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.039 · Cited by 182
Nanotherapy for posterior eye diseases
Kaur, I. P., & Kakkar, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.031 · Cited by 175
Forrest, M. L., Won, C.-Y., Malick, A. W., & Kwon, G. S. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.008 · Cited by 175
Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview
Almeida, H., Amaral, M. H., Lobão, P., & Sousa Lobo, J. M. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.796360 · Cited by 172
Biochemical and biomedical applications of multifunctional magnetic nanoparticles: a review
Huang, S.-H., & Juang, R. (2011) · Journal of Nanoparticle Research · doi:10.1007/s11051-011-0551-4 · Cited by 166
Davis, B. M., Normando, E. M., Guo, L., Turner, L. A., Nizari, S., O'Shea, P., Moss, S. E., Somavarapu, S., & Cordeiro, M. F. (2014) · Small · doi:10.1002/smll.201303433 · Cited by 164
Marano, R. J., Toth, I., Wimmer, N., Brankov, M., & Rakoczy, P. E. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302579 · Cited by 164
Morescalchi, F., Duse, S., Gambicorti, E., Romano, M. R., Costagliola, C., & Semeraro, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/269787 · Cited by 160
Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy?
Pennock, S., Haddock, L. J., Eliott, D., Mukai, S., & Kazlauskas, A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.12.006 · Cited by 158
Suen, W.-L. L., & Chau, Y. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12134 · Cited by 157
Kim, J. H., Kim, M. H., Jo, D. H., Yu, Y. S., Lee, T. G., & Kim, J. H. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.030 · Cited by 157
Chetoni, P., Burgalassi, S., Monti, D., Tampucci, S., Tullio, V., Cuffini, A. M., Muntoni, E., Spagnolo, R., Zara, G. P., & Cavalli, R. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.006 · Cited by 152
Zhou, X., Wong, L. L., Karakoti, A. S., Seal, S., & McGinnis, J. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016733 · Cited by 151
Review: Practical Issues in Intravitreal Drug Delivery
Maurice, D. (2001) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076801753162807 · Cited by 150
Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye
Hironaka, K., Inokuchi, Y., Tozuka, Y., Shimazawa, M., Hara, H., & Takeuchi, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.02.020 · Cited by 143
Cheng, L., Anglin, E. J., Cunin, F., Kim, D., Sailor, M. J., FALKENSTEIN, I. A., Tammewar, A. M., & Freeman, W. R. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.133587 · Cited by 143
Wang, W., Sasaki, H., Chien, D.-S., & Lee, V. H. L. (1991) · Current Eye Research · doi:10.3109/02713689109001766 · Cited by 142
Advances in ocular drug delivery: emphasis on the posterior segment
Kang-Mieler, J. J., Osswald, C. R., & Mieler, W. F. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.935338 · Cited by 142
Qiu, F., Meng, T., Chen, Q., Zhou, K., Shao, Y., Matlock, G., Ma, X., Wu, W., Du, Y., Wang, X., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01319 · Cited by 130
Age‐Related Macular Degeneration
Cheung, L. K., & Eaton, A. (2013) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1264 · Cited by 120
Dendrimer Nanoparticles for Ocular Drug Delivery
Kambhampati, S. P., & Kannan, R. M. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0232 · Cited by 119
Rajala, A., Wang, Y., Zhu, Y., Ranjo-Bishop, M., Ma, J.-X., Mao, C., & Rajala, R. V. S. (2014) · Nano Letters · doi:10.1021/nl502275s · Cited by 117
Varshochian, R., Riazi-Esfahani, M., Jeddi-Tehrani, M., Mahmoudi, A.-R., Aghazadeh, S., Mahbod, M., Movassat, M., Atyabi, F., Sabzevari, A., & Dinarvand, R. (2015) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35446 · Cited by 114
Cho, H., Lai, T. C., & Kwon, G. S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.005 · Cited by 112
Retinitis Pigmentosa: Progress and Perspective
Zhang, Q. (2016) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000227 · Cited by 109
Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes
Lajunen, T., Hisazumi, K., Kanazawa, T., Okada, H., Seta, Y., Yliperttula, M. L., Urtti, A. O., & Takashima, Y. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.04.018 · Cited by 104
Pawar, P. K., Kashyap, H., Malhotra, S., & Sindhu, R. K. (2013) · BioMed Research International · doi:10.1155/2013/341218 · Cited by 103
Dong, Y., Wan, G., Yan, P., Qian, C., Li, F., & Peng, G.-H. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.04.012 · Cited by 100
Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.
Bochot, A., Fattal, E., Boutet, V., Deverre, J. R., Jeanny, J., Chacun, H., & Couvreur, P. (2002) · PubMed · Cited by 98
Lei, H., Rheaume, M.-A., & Kazlauskas, A. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2009.11.003 · Cited by 98
Liu, H.-A., Liu, Y.-L., Ma, Z.-Z., Wang, J.-C., & Zhang, Q. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5891 · Cited by 97
Chow, S. F., Wan, K. Y., Cheng, K. K., Wong, K. W., Sun, C. C., Baum, L., & Chow, A. H. L. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.06.022 · Cited by 97
Self-citationApaolaza, P. S., del Pozo‐Rodríguez, A., Solinís, M. Á., Rodríguez, J. M., Friedrich, U., Torrecilla, J., Weber, B. H. F., & Rodríguez‐Gascón, A. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.004 · Cited by 97
Kambhampati, S. P., Clunies-Ross, A. J. M., Bhutto, I., Mishra, M. K., Edwards, M., McLeod, D. S., Kannan, R. M., & Lutty, G. (2015) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-16250 · Cited by 94
Bashinsky, A. L. (2017) · American Academy of Pediatrics eBooks · doi:10.1542/9781610022309-ch19 · Cited by 94
Inokuchi, Y., Hironaka, K., Fujisawa, T., Tozuka, Y., Tsuruma, K., Shimazawa, M., Takeuchi, H., & Hara, H. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4697 · Cited by 90
The Vitreous Humor As a Barrier to Nanoparticle Distribution
Mains, J., & WILSON, C. G. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0138 · Cited by 89
Advances in Ocular Drug Delivery
Rawas-Qalaji, M., & Williams, C.-A. (2012) · Current Eye Research · doi:10.3109/02713683.2011.652286 · Cited by 89
Intravitreal nanoparticles for retinal delivery
Huang, X., & Chau, Y. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.005 · Cited by 86
Huang, D., Chen, Y.-S., Green, C. R., & Rupenthal, I. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.034 · Cited by 85
Wong, L. L., Hirst, S. M., Pye, Q. N., Reilly, C. M., Seal, S., & McGinnis, J. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058431 · Cited by 82
Kyosseva, S. V., Chen, L., Seal, S., & McGinnis, J. F. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.08.003 · Cited by 82
Sheppard, J. D., Joshi, A. D., Betts, K. A., Hudgens, S. A., Tari, S. R., Chen, N., Skup, M., & Dick, A. D. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.0603 · Cited by 80
Suen, W.-L. L., & Chau, Y. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.004 · Cited by 74
Renno, R. Z., Terada, Y., Haddadin, M. J., Michaud, N. A., Gragoudas, E. S., & Miller, J. W. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.7.1002 · Cited by 73
Nanoparticle–integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats
Kim, H., & Csaky, K. G. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.031 · Cited by 73
Kang-Mieler, J. J., Dosmar, E., Liu, W., & Mieler, W. F. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1227785 · Cited by 73
Human serum albumin nanoparticles for ocular delivery of bevacizumab
Luis de Redín, I., Boiero, C., Martínez-Ohárriz, M. C., Agüeros, M., Ramos, R., Peñuelas, I., Allemandi, D., Llabot, J. M., & Irache, J. M. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.02.003 · Cited by 73
Boddu, S., Gupta, H., & Patel, S. (2014) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/1872211308666140130093301 · Cited by 71
Nanoliposomal minocycline for ocular drug delivery
Kaiser, J. M., Imai, H., Haakenson, J. K., Brucklacher, R. M., Fox, T. E., Shanmugavelandy, S. S., Unrath, K. A., Pedersen, M. M., Dai, P., Freeman, W. M., et al. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.03.004 · Cited by 69
Proteomic analysis of the anti‐inflammatory action of minocycline
Dunston, C. R., Griffiths, H. R., Lambert, P. A., Staddon, S., & Vernallis, A. B. (2011) · PROTEOMICS · doi:10.1002/pmic.201000273 · Cited by 69
Apaolaza, P. S., del Pozo‐Rodríguez, A., Torrecilla, J., Rodríguez‐Gascón, A., Rodríguez, J. M., Friedrich, U., Weber, B. H. F., & Solinís, M. Á. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.033 · Cited by 67
Li, Q., Lai, K. L., Chan, P. S., Leung, S. C., Li, H. Y., Fang, Y., To, K. K. W., Choi, C. H. J., Gao, Q. Y., & Lee, T. W. Y. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.053 · Cited by 67
Self-citationJo, D. H., Kim, J. H., Song, N. W., Song, N. W., Kim, Y. W., Yu, Y. S., Lee, T. G., & Kim, J. H. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.02.007 · Cited by 66
Lee, T. W.-Y., & Robinson, J. R. (2001) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/10807680152729257 · Cited by 66
Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage
Hironaka, K., Inokuchi, Y., Fujisawa, T., Shimazaki, H., Akane, M., Tozuka, Y., Tsuruma, K., Shimazawa, M., Hara, H., & Takeuchi, H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.019 · Cited by 65
ABSENCE OF HISTOLOGIC RETINAL TOXICITY OF INTRAVITREAL NANOGOLD IN A RABBIT MODEL
BAKRI, S. J., PULIDO, J. S., MUKHERJEE, P., MARLER, R. J., & MUKHOPADHYAY, D. (2008) · Retina · doi:10.1097/iae.0b013e3180dc9360 · Cited by 63
Yavuz, B., Bozdağ Pehlivan, S., Sümer Bolu, B., Nomak Sanyal, R., Vural, İ., & Ünlü, N. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12587 · Cited by 62
Photoablation of Human Vitreous Opacities by Light-Induced Vapor Nanobubbles
Sauvage, F., Fraire, J. C., Remaut, K., Sebag, J., Peynshaert, K., Harrington, M. G., de Velde, F. J. V., Xiong, R., Tassignon, M., Brans, T., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b04050 · Cited by 62
Giannaccini, M., Giannini, M., Calatayud, M., Goya, G., Cuschieri, A., Dente, L., & Raffa, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011590 · Cited by 61
High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome
Hashida, N., Ohguro, N., Yamazaki, N., Arakawa, Y., Oiki, E., Mashimo, H., Kurokawa, N., & Tano, Y. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.10.004 · Cited by 59
Defining the Catalytic Activity of Nanoceria in the P23H-1 Rat, a Photoreceptor Degeneration Model
Wong, L., Pye, Q. N., Chen, L., Seal, S., & McGinnis, J. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121977 · Cited by 58
Therapeutic potential of curcumin in major retinal pathologies
Peddada, K. V., Brown, A., Verma, V., & Nebbioso, M. (2018) · International Ophthalmology · doi:10.1007/s10792-018-0845-y · Cited by 58
Pollinger, K., Hennig, R., Ohlmann, A., Fuchshofer, R., Wenzel, R., Breunig, M., Tessmar, J., Tamm, E. R., & Goepferich, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220281110 · Cited by 57
Wu, W., He, Z., Zhang, Z., Yu, X., Song, Z., & Li, X. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.013 · Cited by 57
Magnetic Targeting of Growth Factors Using Iron Oxide Nanoparticles
Marcus, M., Smith, A., Maswadeh, A., Shemesh, Z., Zak, I., Motiei, M., Schori, H., Margel, S., Sharoni, A., & Shefi, O. (2018) · Nanomaterials · doi:10.3390/nano8090707 · Cited by 56
Intravitreal liposome-encapsulated drugs: A preliminary human report
Peyman, G. A., Charles, H. C., Liu, K. R., Khoobehi, B., & Niesman, M. R. (1988) · International Ophthalmology · doi:10.1007/bf00130002 · Cited by 53
Lumi, X., Lužnik, Z., Petrovski, G., Petrovski, B. É., & Hawlina, M. (2016) · BMC Ophthalmology · doi:10.1186/s12886-016-0390-2 · Cited by 53
Wang, Y., Rajala, A., Cao, B., Ranjo-Bishop, M., Agbaga, M.-P., Mao, C., & Rajala, R. V. S. (2016) · Theranostics · doi:10.7150/thno.15230 · Cited by 52
Chemla, Y., Betzer, O., Markus, A., Farah, N., Motiei, M., Popovtzer, R., & Mandel, Y. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0299 · Cited by 52
Park, S. J., Oh, J., Kim, Y., Park, J.-H., Park, J. Y., Hong, H. K., Park, K. H., Lee, J.-W., Kim, H., Chung, J., et al. (2015) · Eye · doi:10.1038/eye.2014.329 · Cited by 51
Ukawala, M., Rajyaguru, T., Chaudhari, K., Manjappa, A. S., Pimple, S. S., Babbar, A. K., Mathur, R., Mishra, A. K., & Murthy, R. S. R. (2012) · Drug Delivery · doi:10.3109/10717544.2012.657721 · Cited by 50
Drug delivery techniques for treating age-related macular degeneration
Schwartz, S. G., Scott, I. U., Flynn, H. W., & Stewart, M. W. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.859135 · Cited by 50
Inhibition of PVR with a Tyrosine Kinase Inhibitor, Dasatinib, in the Swine
Umazume, K., Liu, L., Scott, P. A., de Castro, J. P. F., McDonald, K., Kaplan, H. J., & Tamiya, S. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10418 · Cited by 50
Tzameret, A., Ketter-Katz, H., Edelshtain, V., Sher, I., Corem‐Salkmon, E., Levy, I., Last, D., Guez, D., Mardor, Y., Margel, S., et al. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0438-y · Cited by 49
Patel, S., Garapati, C., Chowdhury, P., Gupta, H., Nesamony, J., Nauli, S., & Boddu, S. H. S. (2015) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2014.0152 · Cited by 48
Lee, J., Goh, U., Lee, H. J., Kim, J., Jeong, M., & Park, J. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00864 · Cited by 48
Tang, M., Ji, X., Xu, H., Zhang, L., Jiang, A., Song, B., Su, Y., & He, Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01580 · Cited by 48
Ocular biocompatibility and tolerance study of biodegradable polymeric micelles in the rabbit eye
Xu, L., Xu, X., Chen, H., & Li, X. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.06.047 · Cited by 47
Shulman, S., Jóhannesson, G., Stefánsson, E., Loewenstein, A., Rosenblatt, A., & Habot‐Wilner, Z. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12744 · Cited by 46
Effect of Growth Factors on Bovine Retinal Pigment Epithelial Cell Migration and Proliferation
Spraul, C. W., Kaven, C., Lang, G. K., & Lang, G. E. (2004) · Ophthalmic Research · doi:10.1159/000077330 · Cited by 46
Magnetic nanoparticles: a strategy to target the choroidal layer in the posterior segment of the eye
Giannaccini, M., Pedicini, L., Matienzo, G. D., Chiellini, E., Dente, L., & Raffa, V. (2017) · Scientific Reports · doi:10.1038/srep43092 · Cited by 46
Intravitreal Pharmacokinetics of Liposome-encapsulated Amikacin in a Rabbit Model
Shuiqing, Z., Hu, C., Houren, W., Lu, Y., Zhang, Y., Yang, J., Yun, G., Zou, W., & Song, B. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31423-5 · Cited by 45
Tisi, A., Passacantando, M., Lozzi, L., Riccitelli, S., Bisti, S., & Maccarone, R. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.03.003 · Cited by 45
Prediction of the Vitreal Half-Life of Small Molecular Drug-Like Compounds
Kidron, H., del Amo, E. M., Vellonen, K., & Urtti, A. O. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0822-5 · Cited by 44
Kalita, D., Shome, D., Jain, V. G., Chadha, K., & Bellare, J. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.01.027 · Cited by 44
Subretinal delivery of immunoglobulin G with gold nanoparticles in the rabbit eye
Hayashi, A., Naseri, A., Pennesi, M. E., & de Juan, E. (2009) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-009-0655-x · Cited by 43
Progress in applications of magnetic nanoparticles in biomedicine
O'Grady, K. (2009) · Journal of Physics D Applied Physics · doi:10.1088/0022-3727/42/22/220301 · Cited by 43
Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage
Suh, W., Nguyen, H. K., Lee, J. E., & Jeong, J. H. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s108452 · Cited by 43
Guo, D. D., Li, Q. N., Li, C. M., & Bi, H. S. (2015) · Cell Proliferation · doi:10.1111/cpr.12163 · Cited by 41
Self-citationAlami-Milani, M., Zakeri-Milani, P., Valizadeh, H., Sattari, S., Salatin, S., & Jelvehgari, M. (2019) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2019.1578370 · Cited by 41
Wong, C. W., & Wong, T. T. L. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-313462 · Cited by 41
Tai, L., Liu, C., Jiang, K., Chen, X., Feng, L., Pan, W., Wei, G., & Lu, W. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.090 · Cited by 39
Xu, L., Li, W., Shi, Q., Li, H., Yang, Z., Liao, D., Li, L., Yang, X., & Zhang, J. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.04.011 · Cited by 39
Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Giannaccini, M., Usai, A., Chiellini, E., Guadagni, V., Andreazzoli, M., Ori, M., Pasqualetti, M., Dente, L., & Raffa, V. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2691-x · Cited by 38
Nor, N. M., Guo, C. X., Rupenthal, I. D., Chen, Y.-S., Green, C. R., & Acosta, M. L. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22829 · Cited by 38
Sun, D., Maeno, H., Gujrati, M., Schur, R., Maeda, A., Maeda, T., Palczewski, K., & Lu, Z. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500192 · Cited by 37
Recent Advances in Treatment of Retinitis Pigmentosa
He, Y., Zhang, Y., & Su, G. (2014) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x09666141027103552 · Cited by 37
Khalid, M. K., Asad, M. I., Henrich‐Noack, P., Sokolov, M., Hintz, W., Grigartzik, L., Zhang, E., Dityatev, A. E., Wachem, B. G. M. V., & Sabel, B. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092613 · Cited by 36
Giacalone, G., Tsapis, N., Mousnier, L., Chacun, H., & Fattal, E. (2018) · Materials · doi:10.3390/ma11101845 · Cited by 36
Kim, K. E., Jang, I., Moon, H., Kim, K. G., Jeoung, J. W., Park, K. H., & Kim, H. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16538 · Cited by 35
Rong, X., Yuan, W., Lü, Y., & Mo, X. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s64100 · Cited by 34
Long, Y., Zhao, X., Clermont, A. C., Zhou, Q., Liu, Q. S., Feener, E. P., Yan, B., & Jiang, G. (2015) · Nanotoxicology · doi:10.3109/17435390.2015.1088589 · Cited by 33
Lee, T. W.-Y., & Robinson, J. R. (2004) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076804772745455 · Cited by 33
Proliferative Vitreoretinopathy
Claes, C. C., & Lafetá, A. P. (2014) · Developments in ophthalmology · doi:10.1159/000360466 · Cited by 33
Liu, Y., & Chiu, G. N. C. (2013) · Biomacromolecules · doi:10.1021/bm401057c · Cited by 32
Pharmacologic Therapy of Ocular Disease
Azar, D. T., & Whitcup, S. M. (2017) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-58290-0 · Cited by 31
Recent developments in liposomal drug delivery systems for the treatment of retinal diseases
Urquhart, A. J., & Eriksen, A. Z. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.04.004 · Cited by 31
Wong, T. Y., Cheung, C. M. G., Larsen, M., Sharma, S., & Simó, R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.30 · Cited by 30
Abrishami, M., Abrishami, M., Mahmoudi, A., Mosallaei, N., Roodi, M. V. A., & Malaekeh‐Nikouei, B. (2016) · Journal of Drug Delivery · doi:10.1155/2016/1368481 · Cited by 29
Non-toxic retention of nanoceria in murine eyes.
Cai, X., Seal, S., & McGinnis, J. F. (2016) · PubMed Central · Cited by 29
Elucidating the role of surface chemistry on cationic phosphorus dendrimer–siRNA complexation
Deriu, M. A., Tsapis, N., Noiray, M., Grasso, G., Brahmi, N. E., Mignani, S. M., Majoral, J., Fattal, E., & Danani, A. (2018) · Nanoscale · doi:10.1039/c8nr01928b · Cited by 28
Vigil, E. M., Sepah, Y. J., Watters, A., Sadiq, M. A., Ansari, M., Bittencourt, M. G., Ibrahim, M., Diana, V., & Nguyen, Q. D. (2015) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-015-0044-1 · Cited by 27
Eibl, K. H., Kook, D., Priglinger, S., Haritoglou, C., Yu, A., Kampik, A., & Welge-L��en, U. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0657 · Cited by 26
Reijerkerk, A., Appeldoorn, C. C. M., Rip, J., de Boer, M., & Gaillard, P. J. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13599 · Cited by 25
Fiscella, R. G., Peyman, G. A., & Ph, F. (1987) · PubMed · Cited by 24
de Freitas, L. G. A., Isaac, D. L. C., Lima, E. M., de Souza, L. G., Abud, M. B., dos Reis, R. G., Tannure, W. T., & de Ávila, M. P. (2018) · Arquivos Brasileiros de Oftalmologia · doi:10.5935/0004-2749.20180079 · Cited by 24
Shen, C., Guo, S., & Lu, C. (2007) · Polymer Degradation and Stability · doi:10.1016/j.polymdegradstab.2007.06.012 · Cited by 23
Olson, J. L., Vélez-Montoya, R., Mandava, N., & Stoldt, C. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9745 · Cited by 23
Lee, T. W.-Y., & Robinson, J. R. (2004) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076804772745464 · Cited by 22
Klingelfus, T., Lirola, J. R., Oya‐Silva, L. F., Disner, G. R., Vicentini, M., Nadaline, J., Robles, J., Trein, L. M., Voigt, C. L., de Assis, H. C. S., et al. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.10.003 · Cited by 20
Lee, T. W.-Y., & Robinson, J. R. (2009) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0010 · Cited by 19
Wan, K. Y., Wong, S. N., Wong, K. W., Chow, S. F., & Chow, A. H. L. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00945 · Cited by 19
Self-citationDąbkowska, M., Rogińska, D., Kłos, P., Sobuś, A., Adamczak, M., Litwińska, Z., Machalińska, A., & Machaliński, B. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s210140 · Cited by 18
Intraocular biodistribution of intravitreal injected chitosan/gelatin nanoparticles.
Moraru, A. D., Costuleanu, M., Sava, A. C., Costin, D., Peptu, C. A., Popa, M., & Chiseliţă, D. (2014) · PubMed · Cited by 17
Said, A. M. A., Zaki, R. G. E., Din, R. A. S. E., Nasr, M., Azab, S. S., & Elzankalony, Y. A. (2017) · BMC Ophthalmology · doi:10.1186/s12886-017-0433-3 · Cited by 15
Xu, X., Xu, Z., Liu, J., Zhang, Z., Chen, H., Li, X., & Shi, S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s109986 · Cited by 11
Uy, H. S., Yu-Keh, E., & Chan, P. S. (2015) · Developments in ophthalmology · doi:10.1159/000438968 · Cited by 8
Absorción de fármacos por vía tópica: Papel de la conjuntiva
Andrés‐Guerrero, V., & Herrero‐Vanrell, R. (2008) · Archivos de la Sociedad Española de Oftalmología · doi:10.4321/s0365-66912008001200001 · Cited by 6
Nanoparticle diffusion in the bovine vitreous
Park, K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.02.017 · Cited by 5
Evaluation of the Use of Pluronic F127 as an Intravitreal Ocular Drug Delivery Vehicle
Su, D., Luu, C. D., Barathi, V. A., Zhu, X., Cheah, E., Cheng, B., & Chee, S.-P. (2006) · Investigative Ophthalmology & Visual Science · Cited by 4
Prolifération vitréo-rétinienne : traitement curatif
Chiquet, C., & Rouberol, F. (2014) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2014.04.002 · Cited by 4
Research works printed but not linked: 9
- 10.18043/ncm.78.2.124 · DOI
- Moraru A. D., 2014, Rom j Morphol Embryol., 55, 869
- Spitznas M., 1974, Adv. Ophthalmol., 28, 78
- Bochot A., 2002, Invest Ophthalmol Vis Sci., 43, 253
- Fiscella R., 1987, Can. J. Ophthalmol., 22, 307
- Rahman M., 2012, Polyester
- 10.1016/j.jconrel.2012.12.005 · DOI · Paper page
- Su D. H., 2006, Invest. Ophthalmol. Vis. Sci., 47, 5122
- Cai X., 2016, Mol. Vis., 22, 1176
Cited by
Nguyen, D. D., Luo, L.-J., Yang, C.-J., & Lai, J.-Y. (2023) · ACS Nano · doi:10.1021/acsnano.2c05824 · Cited by 213
Nanoparticles in ocular applications and their potential toxicity
Cao, Y., Yang, J., Lu, A., Gong, J., Yang, Y., Lin, X., Li, M., & Xu, H. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.931759 · Cited by 119
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment
Jiang, H., & Xu, Z. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2204206 · Cited by 68
“Due to their splendid stability and wide drug loading range, micelles modified with HA have been widely investigated for tumor therapy (W. Li et al., 2020; Zhang, Ren et al., 2020; Yan, Feng et al., 2022).”
BackgroundGreen Light‐Triggered Intraocular Drug Release for Intravenous Chemotherapy of Retinoblastoma
Long, K., Yang, Y., Lv, W., Jiang, K., Li, Y., Lo, A., Lam, W., Zhan, C., & Wang, W. (2021) · Advanced Science · doi:10.1002/advs.202101754 · Cited by 63
Vesicular Drug Delivery Systems: Promising Approaches in Ocular Drug Delivery
Batur, E., Özdemir, S., Durgun, M. E., & Özsoy, Y. (2024) · Pharmaceuticals · doi:10.3390/ph17040511 · Cited by 64
“These obstacles need to be cleared before liposomes are applied topically [39].”
BackgroundInfluential
Metadata
- Authors
- Li, Q., Weng, J., Wong, S. N., Thomas Lee, W. Y., & Chow, S. F.
- Affiliations
- Xi'an Jiaotong University (CN)
- University of Hong Kong (HK)
- Aptorum Group Limited, Unit 232, 12 Science Park West Avenue, Hong Kong Science Park, Shatin New Town, Hong Kong
- Corresponding author
- Chow, Shing Fung
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-06-08
- Volume
- 18
- Issue
- 2
- Pages
- 506-521
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W3033428304
- Cited by
- 59
- References
- 153
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 12 · 2022: 9 · 2021: 8
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Hong Kong (202007002)
- Natural Science Foundation of Shaanxi Province (2020JQ-093)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- nanoparticle drug delivery, retinal drug delivery, ocular drug delivery, age-related macular degeneration, diabetic retinopathy, retinal disease, ocular barriers, translation to clinical practice
- MeSH terms
- Administration, Oral, Animals, Blindness, Blood-Retinal Barrier, Choroid, Conjunctiva, Cornea, Disease Models, Animal, Humans, Ophthalmic Solutions, Permeability, Retina, Retinal Diseases, Sclera, Nanoparticles, Administration, Ophthalmic, Administration, Intravenous, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.